CC
MED icon

Centiva Capital’s Medifast MED Stock Holding History

Centiva Capital’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$224K Buy
22,022
+8,137
+59% +$87.7K 0.01% 1221
2025
Q4 		$148K Buy
+13,885
New +$166K 0.01% 1028
2024
Q4 		– Sell
-15,238
Closed -$292K – 2133
2024
Q3 		$292K Buy
15,238
+898
+6% +$17.3K 0.01% 1596
2024
Q2 		$313K Buy
+14,340
New +$382K 0.02% 1435
2024
Q1 		– Sell
-7,621
Closed -$512K – 2076
2023
Q4 		$512K Buy
7,621
+4,074
+115% +$284K 0.03% 947
2023
Q3 		$265K Buy
+3,547
New +$315K 0.01% 1240
2021
Q3 		– Sell
-747
Closed -$211K – 1501
2021
Q2 		$211K Buy
+747
New +$202K 0.02% 1202

Other funds holding MED

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $48.2B AUM 24.23% 1-Year Est. Return